Brazilian Tuberculosis Research Network

Name

Brazilian Tuberculosis Research Network

Legal name

REDE-TB

Website

https://redetb.org

Company type

Private

Founded year

2001

Operating status

Operating

Ownership category

akta.pro rank

Product category

Public Health Research

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Tuberculosis & Mycobacterial Diseases (HLAKAGAH)

akta.pro secondary industries

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE), Monitoring, Evaluation, Research & Learning (MERL) for Global Health (BPADAIAO)

Keywords

• Tuberculosis research
• Public health networks
• Scientific collaboration
• Health policy evidence
• Research grants

Headquarters

HQ city

Rio De Janeiro

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Research Funding and Grants: As a non-profit scientific organization, REDE-TB operates primarily through funding from national and international agencies including the Brazilian Ministry of Health, PAHO/WHO, and multilateral organizations such as the European Union. Projects are executed with transparent governance and measurable results.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

REDE-TB is a non-profit multidisciplinary scientific network that coordinates tuberculosis research, evidence generation, and policy support in Brazil. It produces scientific evidence, evaluates medications, vaccines, and diagnostics, validates new technologies for integration into the Brazilian Unified Health System (SUS), and builds professional capacity through training across all 27 Brazilian states.

Product overview

REDE-TB (Brazilian Tuberculosis Research Network) is a multidisciplinary nonprofit scientific organization dedicated to strengthening Brazil's national response to tuberculosis. The organization operates as an integrated network combining research, innovation, and public policies. Its portfolio includes research projects (QualiTPT, QualiTPT FASE 2), knowledge repositories (ExpandTPT), diagnostic research initiatives (CAD), knowledge expansion programs (SES-RJ collaboration), and scientific publications (workshop journals). The network integrates academia, government, and civil society to develop and evaluate medicines, vaccines, diagnostics, and control strategies for the Brazilian Unified Health System (SUS).

Differentiator

Problem solved

Functional benefit

Products and services

• QualiTPT Research Project

Quantifiable outcome

• Integration of research, innovation, and public policies across SUS, academia, and society

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core, major and notable.

• Ministério da Saúde (Ministry of Health)coreStrategic or Co-development PartnerNational health authority and primary government partner for tuberculosis control. Collaborates on policy development, technology incorporation, and SUS integration of research findings.
• OPAS/OMS (PAHO/WHO)coreStrategic or Co-development PartnerPan American Health Organization and World Health Organization representation in the Americas. Provides international coordination, technical cooperation, and alignment with global TB control strategies.
• Universidades Brasileiras (Brazilian Universities)coreStrategic or Co-development PartnerNetwork of Brazilian higher education institutions conducting tuberculosis research. Provides scientific expertise, research infrastructure, and human resources for collaborative studies.
• Johns Hopkins University (JHU)majorStrategic or Co-development PartnerPrestigious international research university. Collaborates on scientific production, technology transfer, and global health research initiatives in tuberculosis.
• McGill UniversitymajorStrategic or Co-development PartnerLeading Canadian research university with expertise in global health and tuberculosis. Engages in scientific cooperation and research collaboration.
• BRICS TB NetworknotableStrategic or Co-development PartnerInternational network connecting tuberculosis research efforts among BRICS nations (Brazil, Russia, India, China, South Africa). Enables cross-border collaboration and knowledge sharing.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Barcelona Institute for Global Health (ISGlobal): Spain-based research institute with a substantial tuberculosis research portfolio alongside other global infectious diseases. Comparable as a multidisciplinary non-profit/academic research hub producing TB evidence and policy support.
• BRICS TB Network: Cross-country TB research network linking Brazil, Russia, India, China, and South Africa. REDE-TB is itself a participant, making this a directly comparable network-of-networks peer for collaborative TB research.
• The International Union Against Tuberculosis and Lung Disease (The Union): A Paris-based non-profit scientific organization that coordinates global TB and lung disease research, policy, and training. Most directly comparable to REDE-TB as a multidisciplinary non-profit network generating evidence and convening stakeholders for TB control.
• KNCV Tuberculosis Foundation: Dutch-based TB-focused non-profit operating internationally to eliminate tuberculosis through technical assistance, research, and capacity building. Closely comparable mission and operating model to REDE-TB, with similar grant-funded programmatic structure.
• Stop TB Partnership: Geneva-hosted UN-hosted partnership of countries, donors, and organizations working to eliminate TB. Closely comparable convener role and stakeholder model to REDE-TB at the global level.

Emerging players

• Treatment Action Group (TAG): US-based non-profit advocating for TB and HIV research, policy, and access. Comparable as a TB-focused non-profit producing policy evidence, though more advocacy-driven than research-execution oriented.
• Desmond Tutu TB Centre (Stellenbosch University): African TB research centre affiliated with Stellenbosch University focused on paediatric and adult TB research. Comparable mission of generating TB evidence and contributing to national TB policy, although operating in a different geography.

Broad incumbents

• Instituto Butantan: Major Brazilian public biomedical research and vaccine producer, involved in TB-related vaccine development. A broad incumbent peer in the same country and ecosystem, with overlapping interest in TB diagnostics, vaccines, and public health policy.
• Fundação Oswaldo Cruz (Fiocruz): Brazil's largest public health and biomedical research institution, with significant TB research, vaccine, and diagnostic capacity. A broad incumbent peer operating across many diseases in the same national ecosystem as REDE-TB.
• WHO Global Tuberculosis Programme: The World Health Organization's lead TB technical unit, setting global norms and convening country-level TB research and policy work. Functions as both a partner and a broader institutional reference point for REDE-TB's activities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/redetboficial
• Xx.com/redetuberculose

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brazilian Tuberculosis Research Network